• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

KU14R Antagonist

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS3840135

KU14R is an antagonist of the pancreatic beta-cell atypical imidazoline binding site (putative I3 receptor). KU14R has also been shown to selectively block efaroxan-induced insulin secretion. More details

$265 / 25 mg +1 FREE 8GB USB
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
KU14R, Antagonist
Full Product Name
KU14R
Product Gene Name
KU14R antagonist
Product Synonym Names
KU 14R
Purity/Purification
>98%
Preparation and Storage
Store at -20 degree C for 3 years (powder form); at -20 degree C for 6 months (Solution base)
Molecular Weight
214.26
Solubility
DMSO
Formula
C13H14N2O
SMILES
CCC1 (CC2=CC=CC=C2O1)C3=NC=CN3
CAS Number
189224-48-4

Product Categories/Family for KU14R antagonist

I3 receptor Antagonist

Chemical Structure of KU14R antagonist

KU14R Antagonist – Cat# MBS3840135

Other Notes

Small volumes of KU14R antagonist vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for KU14R purchase

MBS3840135 is an antagonist targeting KU14R.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000